Literature DB >> 23334250

[Hyperfractionated vs. conventionally fractionated radiotherapy of nonmetastatic medulloblastoma].

R-D Kortmann1, H-J Ochel.   

Abstract

Entities:  

Year:  2013        PMID： 23334250     DOI： 10.1007/s00066-012-0292-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  4 in total

1.  Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol.

Authors:  Christian Carrie; Xavier Muracciole; Frédéric Gomez; Jean-Louis Habrand; Mohamed Benhassel; Martine Mege; Marc Mahé; Philippe Quetin; Jean Philippe Maire; Françoise Soum; Marie Helene Baron; Pierre Clavere; Sophie Chapet; Zineb Gaci; Helene Kolodie; Philippe Maingon; Bernard Vie; Valérie Bernier; Claire Alapetite; Sylvette Hoffstetter; Jacques Grill; Frédéric Lafay
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-05-31       Impact factor: 7.038

2.  Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose.

Authors:  Chiaho Hua; Johnnie K Bass; Raja Khan; Larry E Kun; Thomas E Merchant
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-18       Impact factor: 7.038

3.  Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.

Authors:  Charles M Rudin; Christine L Hann; John Laterra; Robert L Yauch; Christopher A Callahan; Ling Fu; Thomas Holcomb; Jeremy Stinson; Stephen E Gould; Barbara Coleman; Patricia M LoRusso; Daniel D Von Hoff; Frederic J de Sauvage; Jennifer A Low
Journal:  N Engl J Med       Date:  2009-09-02       Impact factor: 91.245

4.  Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial.

Authors:  Birgitta Lannering; Stefan Rutkowski; Francois Doz; Barry Pizer; Göran Gustafsson; Aurora Navajas; Maura Massimino; Roel Reddingius; Martin Benesch; Christian Carrie; Roger Taylor; Lorenza Gandola; Thomas Björk-Eriksson; Jordi Giralt; Foppe Oldenburger; Torsten Pietsch; Dominique Figarella-Branger; Keith Robson; Marco Forni; Steven C Clifford; Monica Warmuth-Metz; Katja von Hoff; Andreas Faldum; Véronique Mosseri; Rolf Kortmann
Journal:  J Clin Oncol       Date:  2012-07-30       Impact factor: 44.544
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.